Prevalence of Ototoxicity Following Hematopoietic Stem Cell Transplantation in Pediatric Patients

Kristen Gertson, Susan S. Hayashi, Kathryn Trinkaus, Fei Wan, Robert J. Hayashi

Research output: Contribution to journalArticlepeer-review

Abstract

The use of hematopoietic stem cell transplantation (HSCT) is increasing for a variety of diseases. Ototoxicity from this procedure has not been extensively studied. A retrospective chart review examined 275 patients from this institution who underwent HSCT between January 1, 2007, and April 30, 2017. Data extracted included therapy before HSCT and the subsequent course of transplantation. Evaluable patients had complete medical records and interpretable audiograms available. Ototoxicity constituted significant threshold changes from baseline or changes in International Society of Pediatric Oncology/Boston Ototoxicity Grading Scale (SIOP) grade comparing audiogram results just before HSCT with those following the transplantation procedure. A total of 147 patients were evaluable. Ototoxicity was observed in 10.2% of the patients. Higher SIOP grade before HSCT was significantly associated with a higher risk of post-transplantation ototoxicity (P <. 01). Previous cisplatin treatment (P <. 0001), but not carboplatin or radiation treatment, was also associated with ototoxicity. Patients with a solid tumor or brain tumor (P <. 0001) and those who received an autologous transplant (P = .0002) were also at increased risk. No post-transplantation event was significantly associated with ototoxicity. Ototoxicity affects a significant percentage of patients undergoing HSCT, and careful monitoring is needed to identify patients impacted by this procedure.

Original languageEnglish
Pages (from-to)107-113
Number of pages7
JournalBiology of Blood and Marrow Transplantation
Volume26
Issue number1
DOIs
StatePublished - Jan 2020

Keywords

  • Ototoxicity
  • Pediatric
  • Stem cell transplantation

Fingerprint Dive into the research topics of 'Prevalence of Ototoxicity Following Hematopoietic Stem Cell Transplantation in Pediatric Patients'. Together they form a unique fingerprint.

Cite this